Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
Quarterly results
Director comp.
Credit agrmnt [a]
Appointed director
|
|
Pear Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/17/2023 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits I... |
| 02/24/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/03/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 08/11/2022 |
8-K
| Quarterly results |
| 07/25/2022 |
8-K
| Quarterly results |
| 06/24/2022 |
8-K
| Quarterly results |
| 06/15/2022 |
8-K
| Quarterly results |
| 06/06/2022 |
8-K
| Quarterly results |
| 05/16/2022 |
8-K
| Quarterly results |
| 05/12/2022 |
8-K
| Quarterly results |
| 03/28/2022 |
8-K
| Quarterly results |
| 01/18/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 01/11/2022 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits I... |
| 12/07/2021 |
8-K
| Asset disposition, Director compensation was amended/approved, Credit agreement amendment|
Docs:
|
"Second Amended and Restated Certificate of Incorporation of Thimble Point Acquisition Corp",
"Amended and Restated Bylaws of Pear Therapeutics, Inc",
"Amended and Restated Registration Rights Agreement",
"Pear Therapeutics, Inc. 2021 Stock Option and Incentive Plan",
"Pear Therapeutics, Inc. 2021 Employee Stock Purchase Plan",
"Form of Incentive Stock Option Agreement under the Pear Therapeutics, Inc. 2021 Stock Option and Incentive Plan",
"Form of Restricted Stock Award Agreement under the Pear Therapeutics, Inc. 2021 Stock Option and Incentive Plan",
"Form of Restricted Stock Unit Award Agreement under the Pear Therapeutics, Inc. 2021 Stock Option and Incentive Plan",
"Form of Rollover Incentive Stock Option Agreement under the Pear Therapeutics, Inc. 2021 Stock Option and Incentive Plan",
"Amended and Restated Registration Rights Agreement" |
|
| 11/30/2021 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 11/23/2021 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events Interactive Data |
| 11/22/2021 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 11/15/2021 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data |
| 06/22/2021 |
8-K
| Quarterly results |
| 05/24/2021 |
8-K
| Quarterly results |
| 02/04/2021 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office...|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report : February 4, 2021 Thimble Point Acquisition Corp. Delaware 001-39969 85-4103092 195 Church Street, 15 th Floor New Haven, Connecticut 06510 Registrant's telephone number, including area code: 680-8543 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchan...",
"Underwriting Agreement, by and among the Company, Citigroup Global Markets, Inc. and Credit Suisse Securities (USA) LLC",
"Amendment to the Amended and Restated Certificate of Incorporation",
"Amended and Restated Certificate of Incorporation",
"Bylaws",
"Warrant Agreement, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent",
"Letter Agreement, by and among the Company, its executive officers, its directors, advisors and LJ10 LLC",
"Investment Management Trust Agreement, by and between the Company and Continental Stock Transfer & Trust Company, as trustee",
"Registration Rights Agreement, by and among the Company, LJ10 LLC and the other holders party thereto",
"Private Placement Warrants Purchase Agreement, by and between the Company and LJ10 LLC",
"Form of Indemnity Agreement between the Company and each of the officers and directors of the Company" |
|
|
|